|
|
||||||||
Department of Medicine, National Jewish Medical and Research Center, and Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80206
| |
ABSTRACT |
|---|
|
|
|---|
We have investigated the role of the cytoskeleton in surfactant protein gene expression. Cytochalasin D (CD), colchicine (Col), or nocodazole (Noco) were tested on primary cultures of adult rat alveolar type II cells. Treatment with any of the drugs did not result in dramatic cell shape changes, but ultrastructural examination revealed that the cytoplasm of cells treated with CD was markedly disorganized; cells treated with Col did not exhibit such changes. Treatment with any of the three drugs resulted in a reduction in surfactant protein (SP) mRNAs. These decreases were not the result of cell toxicity, since overall protein synthesis was unimpaired by drug treatment. Washing the cells followed by an additional 2 days of culture resulted in a reaccumulation of SP mRNAs in CD-treated cells but not in Col-treated cells. Washing of Noco-treated cultures resulted in partial recovery. SP mRNA stability was estimated in the presence or absence of cytoskeleton-disrupting drugs. Disruption of either microfilaments or microtubules significantly affected the half-lives of mRNAs for SP-A, SP-B, and SP-C. These data support a role for the cytoskeleton in the maintenance of type II cell differentiation and suggest that the role of the cytoskeleton is at least in part to stabilize SP mRNAs.
lung; pulmonary surfactant
| |
INTRODUCTION |
|---|
|
|
|---|
A PRIMARY FUNCTION of alveolar type II cells is the synthesis and secretion of pulmonary surfactant, which is a complex of phospholipids and the lung-specific surfactant protein (SP)-A, SP-B, and SP-C (18). Because of the heterogeneity of cell types in the lung, many studies on the regulation of type II cell differentiated function have been carried out on purified type II cell populations in vitro. One consistent result from these studies has been that type II cells maintained on a tissue culture plastic substratum rapidly lose most markers of differentiated function. A number of investigators have attempted to improve maintenance of type II cell differentiation by culturing cells on more biological substrata, with varying degrees of success (24). Previous work from our laboratory has shown that type II cells cultured on a reconstituted basement membrane gel derived from the Engelbreth-Holm-Swarm (EHS) tumor, or in association with fetal rat lung fibroblasts on floating collagen gels, exhibit significantly improved maintenance of differentiation as gauged by morphology (14, 27, 29), patterns of phospholipid biosynthesis (14, 27, 29), production of SP-A protein (27), accumulation of mRNAs for SP-A, SP-B, and SP-C (27, 28), and the ability to respond to hormones (14). We have attributed the beneficial effects of these culture systems to the establishment of requisite cell-extracellular matrix interactions and cell-cell interactions, as well as to the maintenance of native type II cuboidal cell shape.
The importance of normal cell shape to type II cell function is underscored by our demonstration that known markers of type II cell differentiation (morphology, patterns of phospholipid biosynthesis, and accumulation of SP mRNAs) modulate with changes in cell shape (28). Because cell shape reflects intracellular cytoskeletal organization, we hypothesized that perturbations to cytoskeletal elements would result in altered lung-specific gene expression. In this paper, we demonstrate that disruption of either microfilaments or microtubules leads to the depletion of mRNAs for SP-A, SP-B, and SP-C and that this results at least in part from decreased mRNA stability.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Isolation of alveolar type II cells. Alveolar type II cells were dissociated from the lungs of specific pathogen-free adult male Sprague-Dawley rats (Bantin Kingman, Fremont, CA) with porcine pancreatic elastase (Worthington Biochemicals, Freehold, NJ). Type II cells were further purified by the immunoglobulin G panning method (9) and then resuspended in culture medium, which was Dulbecco's modified Eagle's medium (DMEM; GIBCO BRL, Gaithersburg, MD) containing 5% whole rat serum (Pel Freeze, Rogers, AK), 100 U/ml penicillin, 100 µg/ml streptomycin, 2.5 µg/ml amphotericin B (all from GIBCO BRL), and 10 µg/ml gentamicin sulfate (Sigma Chemical, St. Louis, MO).
Cell culture method and drug treatments. Two culture systems, both of which have been shown to support improved type II cell differentiation, were used in these experiments. The first system involves plating type II cells onto a feeder layer of lethally irradiated fetal rat lung fibroblasts grown on a rat tail collagen gel (29). Type II cells suspended in culture medium were seeded onto irradiated day 19 fetal rat lung fibroblasts feeder layers at a concentration of 5 × 105 cells/cm2; the day of seeding was considered day 0 of culture. On day 1 of culture, the medium was changed to remove nonadherent type II cells, and then the gel-fibroblast-type II cell complexes were detached from the culture dish and allowed to float free in the medium (hereafter floating gel cultures). In the second system, type II cells were seeded at a density of 5 × 105 cells/cm2 into six-well cluster dishes that contained 1 ml Engelbreth-Holm-Swarm (EHS) matrix (Collaborative Biomedical Products, Waltham, MA). Depending on the experimental design, cultures were maintained for 8-10 days in both systems, with medium changes on alternate days.
Treatment with cytoskeleton-disrupting drugs was initiated on day 7 of culture and was continued for 24 h. Microfilaments were disrupted with 5 µM cytochalasin D (CD; Sigma) in dimethyl sulfoxide (Sigma; final concentration 0.1%). Microtubules were disrupted with either 2.5 µM colchicine (Col; Sigma), or 10 µM nocodazole (Noco; Sigma) dissolved in sterile phosphate-buffered saline (PBS, pH 7.4). These concentrations have been shown to be effective in disrupting cytoskeletal elements in other systems (1-5, 11, 15, 33), including type II cells (7, 10). Medium with no additions and vehicle-only additions served as controls. In experiments designed to determine if the effects of the cytoskeleton-disrupting drugs were reversible, treated cultures were washed four times for 15 min with 5 ml of DMEM. Fresh culture medium was then added, and the cultures were maintained an additional 2 days until harvest.
Isolation of RNA and Northern blot
analysis. For RNA extraction, cultured cells were lysed
in 4 M guanidinium isothiocyanate, 0.5% laurylsarcosine, and 0.1 M
-mercaptoethanol in 25 mM sodium citrate buffer (GITC). RNA was
isolated by ultracentrifugation over a CsCl cushion, size fractionated
by electrophoresis through a denaturing 1% agarose gel, and
transferred to Nytran (Schleicher and Schuell, Keene, NH) by
capillary action. Northern blots were probed with cDNAs for rat SP-A,
SP-B, SP-C, human
-actin, and human glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) that had been radiolabeled to high specific
activity with
[
-32P]dCTP (ICN
Pharmaceuticals, Costa Mesa, CA) by random-primed second-strand
synthesis using a commercially available kit (GIBCO BRL). Hybridization
and washing of blots were performed as previously described (28).
Determination of mRNA stability. The stability of mRNAs for SP-A, SP-B, SP-C, and GAPDH in the presence and absence of cytoskeleton-inhibiting drugs was determined by measuring their rate of degradation after inhibition of RNA transcription. These experiments were only done using cells cultured on EHS gels. RNA synthesis was inhibited by addition of actinomycin D (Act D; 10 mg/ml; Calbiochem, La Jolla, CA); this concentration of Act D inhibited the incorporation of radiolabeled uridine into type II cell RNA over a 12-h period by 98% (data not shown). On day 8 of culture, cells were treated with Act D alone, Act D plus CD, or Act D plus Col. Cells were harvested into GITC 3, 6, 9, and 12 h after addition of the drugs. Cultures treated with CD or Col alone, their appropriate vehicle controls, or no additions served as controls. RNA was isolated, and Northern blots were prepared. Direct quantitation of hybridized signal was done using a phosphorus screen and ImageQuant software version 3.3 (Molecular Dynamics, Sunnyvale, CA).
Protein synthesis. After 20 h of
exposure to either CD, Col, Noco, or the appropriate vehicle control
beginning on day 7 of culture, cells
were incubated for 4 h in culture medium containing 25 µCi/ml
[35S]methionine
(Tran35S-Label; ICN). At the end
of the incubation period, floating gel cultures were washed two times
with PBS and then transferred to 9 ml of DMEM containing 10% fetal
bovine serum (GIBCO BRL) and 0.1% collagenase (CLS I; Worthington) and
were incubated at 37°C for 1-1.5 h to digest the gel. The
cells were collected by centrifugation at 200 g for 10 min, washed two times in PBS,
resuspended in 1 ml of PBS containing 1 mM phenylmethylsulfonyl
fluoride, 5 mM N-ethylmaleimide, and 5 mM EDTA (all from Sigma), and then stored at
20°C until
analysis. After being washed with PBS, the cells in EHS cultures were
digested free of the substratum by incubation with 2 ml of dispase
(Collaborative Biomedical) for 1-1.5 h at 37°C. The dispersed
cell aggregates were then collected, washed, and stored as described
for floating gel cultures.
Cell pellets were thawed on ice and then sonicated with two 30-s bursts from a Branson 200 Sonifier equipped with a microtip. Duplicate aliquots of lysate were precipitated with trichloroacetic acid (10% final concentration) and collected on glass fiber filters (Whatman GF/C, Hillsboro, OR), and then incorporated counts were determined by scintillation counting and normalized to DNA content.
Morphology. Treated and untreated cells cultured in the floating gel system were fixed in 2% glutaraldehyde-4% paraformaldehyde, postfixed in 1.5% osmium tetroxide, stained en bloc with uranyl acetate, and embedded in Polybed 812 (Polysciences, Warrington, PA). Blocks were sectioned perpendicular to the plane of the culture substratum and stained as described previously (29).
Statistics. Data were analyzed for statistical significance by two-way analysis of variance (ANOVA) using the JMP 3.0.2 computer software package (SAS Institute, Cary, NC). For each condition, individual 95% confidence intervals were constructed using a pooled estimate of the standard error obtained from the ANOVA table. A value of P < 0.05 was considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Morphology. Treatment with either CD, Col, or Noco had no effect on the gross morphology of cultured type II cells when viewed by light microscopy. As shown in Fig. 1, cross sections of type II cells cultured on floating gels demonstrated that the cells retained a cuboidal morphology in all treatment groups. When viewed in the electron microscope, however, clear differences were observed. Untreated type II cells cultured on floating collagen gels appeared as previously described (28, 29). The cells had a cuboidal shape and contained abundant osmiophilic lamellar bodies (Fig. 2). The apical cell surfaces, although lined with many microvilli, appeared colinear. In contrast, CD caused a disorganization of the cytoplasm that was particularly evident in cell apexes (Fig. 3). The majority of the microvilli had disappeared, and the apical portion of the cells, which protruded prominently into the luminal (medium) space, appeared to undulate from cell to cell. In many of these cells, the apical cytoplasm appeared to be nearly devoid of organelles. Cells treated with Col did not exhibit the drastic changes in morphology seen with CD (Fig. 4). Although there was some protuberance of the apical portions of the cells into the medium, it was not as pronounced as that seen with CD; furthermore, apical microvilli appeared to be unaffected. The overall intracellular organization of the cells did not appear to be obviously disrupted to the extent that it was difficult to distinguish Col-treated cells from untreated cells.
|
|
|
|
SP gene expression. Disruption of
microfilaments with CD and microtubules with Col had significant
effects on the accumulation of mRNAs for SP-A, SP-B, and SP-C. In both
the floating gel (Fig. 5) and the EHS gel
(Fig. 6) culture systems, treatment with
either CD or Col for the 24 h between days
7 and 8 resulted in
pronounced decreases in the steady-state levels of all three SP mRNAs
to the point that they were barely detectable. In contrast, the
expression of GAPDH, which was used as a constitutive marker, was
essentially unaffected. Expression of
-actin mRNA was unaffected by
treatment with Col but was significantly increased by CD, which may be
due to an increase in gene transcription (32).
|
|
To determine if the observed effects were due to cell toxicity, we measured overall protein synthesis in treated and untreated cultures (Table 1). The results showed that neither CD nor Col inhibited protein synthesis; in contrast, each drug significantly stimulated protein synthesis compared with controls. Noco, another microtuble-disrupting drug, also appeared to stimulate protein synthesis, but the differences were not statistically significant. Importantly, treatment with any of the drugs had no effect on the amount of DNA per culture (data not shown), also indicating that the drugs were not toxic.
|
We next determined if the effects of the cytoskeleton-disrupting drugs
were reversible. Cells in both culture systems were maintained for 7 days and then were exposed to the cytoskeleton-disrupting drugs for 24 h. At this point, the cultures were repeatedly washed with drug-free
medium, given fresh medium, and then cultured for an additional 2 days
in the absence of drugs before analysis. The data are presented in
Figs. 7 and 8.
As expected, in both culture systems, treatment with CD, Col, and Noco
for 24 h resulted in a marked decrease in SP mRNAs on
day 8. In the floating gel system
(Fig. 7), washing out CD resulted in increased accumulation of all
three SP mRNAs on day 10. Washing
CD-treated floating gel cultures also resulted in a restoration of
intracellular organization when viewed by electron microscopy (data not
shown). The results of washing out CD in the EHS gel system also
resulted in increased SP gene expression (Fig. 8) but to a lesser
extent than that seen in floating gel cultures; whereas SP mRNAs in
washed CD-treated floating gel cultures recovered to levels at or
exceeding those seen in untreated day
10 cultures, SP mRNA levels in washed CD-treated EHS
gel cultures did not recover to those seen in untreated
day 10 cultures. Compared with
CD-treated cells on both substrata, levels of
-actin were decreased
in washed CD-treated cultures but still remained above those seen in
untreated controls. Levels of GAPDH mRNA remained relatively constant
over the course of the entire experiment regardless of substratum.
|
|
Washing Col-treated cultures did not restore SP mRNAs, most likely because Col irreversibly binds tubulin monomers. We therefore tested Noco, which is more reversible than Col. Washing of Noco-treated floating gel cultures resulted in recovery of mRNA levels for all three SPs to levels similar to those seen in untreated day 10 cultures. Washing of Noco-treated EHS gel cultures, however, was ineffective in restoring SP mRNA levels.
Effect of CD and Col on SP mRNA stability. The effect of CD and Col on the stability of mRNAs for SP-A, SP-B, SP-C, and GAPDH was assessed by using Act D to inhibit RNA synthesis. Cultures were treated with Act D, Act D plus CD, and Act D plus Col for up to 12 h, with samples taken every 3 h for Northern analysis. Because of the potential toxic effects of long-term treatment with Act D, we did not examine time points beyond 12 h. Representative Northern blots of the effects of CD and Col treatment are presented in Figs. 9 and 10, respectively; summary data from four to five independent experiments are shown in Fig. 11. Despite the fact that the concentration of Act D used in these experiments (10 µg/ml) inhibited RNA synthesis by 98%, the steady-state levels of mRNAs for all three SPs in the presence of Act D alone did not decline appreciably over the 12-h test period. These data suggest that SP mRNAs have a relatively long half-life in the EHS culture system. Treatment with CD significantly destabilized all three SP mRNAs, with the effect on SP-A and SP-B mRNAs being slightly greater than that seen for SP-C. In contrast, GAPDH mRNA levels, which declined slightly in the presence of Act D alone, were not significantly affected by the addition of CD. Treatment with Col also resulted in destabilization of the SP mRNAs, but the effects were not as pronounced as those seen with CD. GAPDH mRNA levels in the presence of Act D plus Col were not significantly lower than those seen with Act D alone.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
In these experiments, we have investigated the role of the cytoskeleton in the maintenance of SP gene expression in primary cultures of rat type II cells. The data show that disruption of either microfilaments or microtubules causes a markedly reduced accumulation of mRNAs for SP-A, SP-B, and SP-C and that this results at least in part from decreases in the stability of these mRNAs. Under the same conditions, GAPDH mRNA was essentially unaffected. This lack of an effect of CD or Col on GAPDH mRNA stability indicates that not all mRNAs require association with an intact cytoskeleton for stabilization (see below). A recent study by Dobbs and co-workers (10) has shown that long-term cultures of rat type II cells treated with Noco have reduced levels of SP-A, SP-B, and SP-C mRNAs, whereas cells treated with CD were unaffected. The disparity between these data and the results reported here could be due to differences in the concentration of CD used. Dobbs et al. used CD at concentrations of 1 and 100 nM, whereas the concentration used in our experiments was 5 µM, which was within the concentration range used in other studies (1-5, 7, 10, 11, 15, 33). Notable among these are the results of Beresford and Agius (3), who observed that glucokinase mRNA expression was stimulated by 100 nM CD but was depressed by concentrations of 2-20 µM.
Because we observed little decline in the levels for all three SP mRNAs
using a concentration of Act D that inhibited RNA synthesis by 98%
over 12 h, our data indicate that mRNAs for SP-A, SP-B, and SP-C are
relatively long lived in our primary cultures of adult type II cells.
Using cultured human fetal lung explants, Venkatesh et al. (34)
determined the half-lives for SP-B and SP-C mRNAs in the presence of
dexamethasone to be 16 and 19 h, respectively. Treatment of cultured
fetal rabbit lung explants with dexamethasone increased the half-life
of SP-C mRNA to 30 h (6). The long half-lives that we observed for SP-B
and SP-C are consistent with these observations, since our cells were
cultured in the presence of whole rat serum, which most likely contains corticosteroids. Our data also suggest that the half-life of SP-A mRNA
in our cultures of primary type II cells is somewhat longer than that
observed in human fetal lung explants (6, 13) in which
10
7 M dexamethasone
decreased SP-A mRNA half-life. The possible effects of serum
glucocorticoids in our cultures are difficult to estimate, since SP-A
mRNA and protein expression can vary in response to both the
concentration of glucocorticoid and the length of exposure (13, 17,
23). We also do not know if the differences in SP-A mRNA half-life that
we observed are due species differences, to the behavior of isolated
type II cells in culture, or to some other unknown factor(s).
Earlier studies from our laboratory indicated that type II cell differentiation was improved when the cells were allowed to assume their native cuboidal shape (27-29). Because CD- and Col-treated cells appear cuboidal in cross section, cell shape per se may not be as important to type II cell differentiation as how shape reflects intracellular structural organization, which is predominantly determined by the cytoskeleton. The data presented here demonstrate that perturbing cytoskeletal organization has a negative impact on normal cell function. Support for this concept is suggested by our previous work (28) in which type II cells were cultured on both attached and floating collagen gels. SP mRNAs did not accumulate in the attenuated cells in attached gel cultures, even though nuclear run-on assays demonstrated that nuclei from these cells were transcribing mRNAs for SP-A, SP-B, and SP-C. The lack of accumulation of any of the SP mRNAs suggests that these mRNAs were destabilized in cells on attached gels. Ultrastructural examination of type II cells cultured on attached and floating collagen gels revealed differences in cytoskeletal organization, the most notable being the presence of dense accumulations of microfilaments in the basal region of cells on attached gels. Releasing the collagen gels from the culture dish resulted in cell shape changes that were accompanied by changes in cytoskeletal organization, since these prominent microfilament bundles disappeared. Significantly, detaching the gels also resulted in the cells reaccumulating mRNAs for SP-A, SP-B, and SP-C to readily detectable levels as soon as 24 h after detachment. Combining these data with the observations in the present study, we hypothesize that type II cells on attached gels transcribe SP mRNAs but that cytoskeletal changes imposed by the pronounced spreading of the cells over the substratum do not allow these mRNAs to associate with the cytoskeleton in a manner that confers stability, and thus the mRNAs are degraded. Detaching the gels results in the reorganization of the cytoskeleton to a more normal configuration that allows association and stabilization of the SP mRNAs and hence their reaccumulation.
Our observations on the effects of disrupting the cytoskeleton on cell
differentiation are also not unique among epithelial cells. Using
primary cultures of rat mammary epithelial cells maintained on a
laminin substratum, Blum et al. (4) demonstrated that treatment with
either CD or Col for 24 h resulted in a marked decrease in the
accumulation of the milk proteins
-casein, transferrin, and
-lactalbumin. This resulted from decreases in the mRNAs for these
proteins, which were in turn shown to be destabilized by treatment with
the drugs (5). Treatment of primary cultures of hepatocytes with CD
resulted in decreased expression of P-glycoprotein, which resulted from
rapid destabilization of P-glycoprotein mRNA in the absence of any
change in its rate of transcription (15). Similarly, incubation
of insulin-treated hepatocytes with CD at the same concentration
used in our experiments resulted in increased degradation of
glucokinase mRNA (3).
The role of the cytoskeleton in maintenance of gene expression is not
as simple as the data discussed above would imply. Because overall
protein synthesis is actually increased in type II cell cultures
treated with CD or Col, disruption of the cytoskeleton cannot lead to
the depletion of all mRNAs. Treatment with CD and Col may, in fact,
cause the upregulation of certain genes. This possibility is supported
by evidence from cultures of other cell types. Fibroblasts treated with
either CD, Col, or Noco respond with major increases in urokinase
plasminogen activator receptor mRNA and protein (2). Human dermal
fibroblasts treated with CD exhibit a shape-related induction in
expression of transforming growth factor-
mRNA and protein (33).
L929 cells treated with Col, Noco, or vinblastine to disrupt
microtubules show increased expression of nerve growth factor mRNA and
protein, whereas GAPDH mRNA is unaffected; CD had no effect on the
cells (1). The sum of the data detailing the positive and negative
effects of CD and Col on gene expression is that the effects of
disrupting the cytoskeleton on any given gene must be determined
empirically.
How does the cytoskeleton affect gene expression? Several studies have demonstrated that polysomes bind to the cytoskeleton (11) and that these polysomes contain specific mRNAs that are associated with the cytoskeleton by their poly(A) tails. How this association confers stability on the mRNAs is not understood. A growing literature also supports the hypothesis that specific mRNAs are transported and localized to very specific locations within the cell and that cytoskeletal elements are involved both in targeting and anchoring these mRNAs. The structural elements that distinguish cytoskeleton-bound polysomes from either free polysomes or polysomes associated with the endoplasmic reticulum, however, are not well defined. All available evidence suggests that subcellular targeting of specific mRNAs is mediated by sequences in the 3' untranslated region of these mRNAs (for review see Ref. 12 and references therein).
The cytoskeleton may also be involved in supporting functional
differentiation by mechanisms other than stabilizing particular mRNAs.
Cultured mammary epithelial cells, like alveolar type II cells, require
an interaction with the extracellular matrix to sustain tissue-specific
gene expression in the presence of lactogenic hormones (16, 30). This
requirement has been more precisely defined to be for laminin (31).
Type II cells cultured on EHS tumor matrix, which is composed
predominantly of laminin, form alveolus-like structures (29).
Alveolus-like structure formation is dependent on laminin (19) as well
as on an uncharacterized activity of <10-kDa molecular mass (20).
Laminin binds to cells via both integrin and non-integrin receptors
(21). The morphological and biochemical differentiation induced in
mammary epithelial cells by laminin requires a functional
1-integrin receptor (16, 25).
This observation is particularly interesting in light of the
accumulating body of evidence that many of the well-characterized signal transduction pathways for growth factors and cytokines are also
activated by integrins (26, 35). Such activation may involve elements
of the cytoskeleton, since, in several systems, CD will disrupt
integrin-mediated signaling occurring via tyrosine kinases (8, 22).
Thus, although our data suggest an important role for the cytoskeleton
in the stabilization of SP mRNAs, we cannot rule out the possibility
that disruption of the actin cytoskeleton with CD also inhibits
transcription of these genes. This possibility is suggested by our
earlier observations on transcription of SP mRNAs by type II cells
cultured on attached versus floating collagen gels (28). As discussed
above, type II cells on attached gels transcribed SP mRNAs but did not
accumulate them, which we hypothesize is due to mRNA instability
resulting from cytoskeletal reorganization. It should be noted,
however, that the transcription of SP mRNAs in nuclei from cells on
attached gels was somewhat less than that seen in nuclei from cells on
floating gels. Thus it is possible that normal cytoskeletal
organization in the type II cell may be serving as a chemomechanical
bridge between the extracellular matrix and the nucleus and that
perturbations resulting from cell flattening may effect a
downregulation of SP gene transcription.
In summary, expression of mRNAs for SP-A, SP-B, and SP-C in cultured type II cells is greatly reduced by disruption of either microfilaments or microtubules, which act to stabilize these mRNAs. These results demonstrate that an intact cytoskeleton is required to maintain this aspect of type II cell differentiation, even when the cells exhibit their normal cuboidal shape. These data, when considered with the changes in cytoskeletal organization that must occur when type II cells are cultured on inflexible substrata such as tissue culture plastic, suggest a possible explantation for the rapid loss of SP gene expression under those conditions.
| |
ACKNOWLEDGEMENTS |
|---|
This work was performed in the Lord and Taylor Laboratory for Lung Biochemistry and the Anna Perahia Adatto Clinical Research Center. We thank Janet Leiber for performing the electron microscopy and Leigh Landskroner and Barry Silverstein for preparing the figures. We also thank Kathy Ryan Morgan for excellent assistance in preparing the manuscript.
| |
FOOTNOTES |
|---|
This work was supported by National Heart, Lung, and Blood Institute Specialized Center for Research Grants HL-27353 and HL-56556.
Address for reprint requests: J. M. Shannon, National Jewish Medical and Research Center, 1400 Jackson St., Denver, CO 80206.
Received 16 June 1997; accepted in final form 25 September 1997.
| |
REFERENCES |
|---|
|
|
|---|
1.
Baudet, C.,
P. Naveilhan,
F. Jehan,
P. Brachet,
and
D. Wion.
Expression of the nerve growth factor gene is controlled by the microtubule network.
J. Neurosci. Res.
41:
462-470,
1995[Medline].
2.
Bayraktutan, U.,
and
P. Jones.
Expression of the human gene encoding urokinase plasminogen activator receptor is activated by disruption of the cytoskeleton.
Exp. Cell Res.
221:
486-495,
1995[Medline].
3.
Beresford, G. W.,
and
L. Agius.
Cytochalasin D exerts stimulatory and inhibitory effects on insulin-induced glucokinase mRNA expression in hepatocytes.
Mol. Cell. Biochem.
139:
177-184,
1994[Medline].
4.
Blum, J. L.,
and
M. S. Wicha.
Role of the cytoskeleton in laminin induced mammary gene expression.
J. Cell. Physiol.
135:
13-22,
1988[Medline].
5.
Blum, J. L.,
M. E. Zeigler,
and
M. S. Wicha.
Regulation of mammary differentiation by the extracellular matrix.
Environ. Health Perspect.
80:
71-83,
1989[Medline].
6.
Boggaram, V.,
and
R. K. Margana.
Developmental and hormonal regulation of surfactant protein C (SP-C) gene expression in fetal lung. Role of transcription and mRNA stability.
J. Biol. Chem.
269:
27767-27772,
1994
7.
Brown, L. A. S.,
S. M. Pasquale,
and
W. J. Longmore.
Role of microtubules in surfactant secretion.
J. Appl. Physiol.
58:
1866-1873,
1985
8.
Clark, E. A.,
and
J. S. Brugge.
Integrins and signal transduction pathways: the road taken.
Science
268:
233-239,
1995
9.
Dobbs, L. G.,
R. Gonzalez,
and
M. C. Williams.
An improved method for isolating type II cells in high yield and purity.
Am. Rev. Respir. Dis.
134:
141-145,
1986[Medline].
10.
Dobbs, L. G.,
M. S. Pian,
M. Maglio,
S. Dumars,
and
L. Allen.
Maintenance of the differentiated type II cell phenotype by culture with an apical air surface.
Am. J. Physiol.
273 (Lung Cell. Mol. Physiol. 17):
L347-L354,
1997
11.
Fey, E. G.,
D. A. Ornelles,
and
S. Penman.
Association of RNA with the cytoskeleton and the nuclear matrix.
J. Cell Sci. Suppl.
5:
99-119,
1986.
12.
Hesketh, J. E.
Sorting of messenger RNAs in the cytoplasm: mRNA localizatoin and the cytoskeleton.
Exp. Cell Res.
225:
219-236,
1996[Medline].
13.
Iannuzzi, D. M.,
R. Ertsey,
and
P. L. Ballard.
Biphasic glucocorticoid regulation of pulmonary SP-A: characterization of inhibitory process.
Am. J. Physiol.
264 (Lung Cell. Mol. Physiol. 8):
L236-L244,
1993
14.
Kawada, H.,
J. M. Shannon,
and
R. J. Mason.
Improved maintenance of adult rat alveolar type II cell differentiation in vitro: effect of serum-free, hormonally defined medium and a reconstituted basement membrane.
Am. J. Respir. Cell Mol. Biol.
3:
330-343,
1990.
15.
Lee, C. H.,
G. Bradley,
and
V. Ling.
Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability.
Cell Growth Differ.
6:
347-354,
1995[Abstract].
16.
Lelievre, S.,
V. M. Weaver,
and
M. J. Bissell.
Extracellular matrix signaling from the cellular membrane skeleton to the nuclear skeleton: a model of gene regulation.
Recent Prog. Horm. Res.
51:
417-431,
1996.
17.
Liley, H.,
R. White,
B. Benson,
and
P. Ballard.
Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung.
Proc. Natl. Acad. Sci. USA
85:
9096-9100,
1988
18.
Mason, R. J.,
and
J. M. Shannon.
Alveolar type II cells.
In: The Lung: Scientific Foundations (2nd ed.), edited by R. G. Crystal,
J. B. West,
P. J. Barnes,
N. S. Cherniack,
and E. R. Weibel. Philadelphia, PA: Lippincott-Raven, 1997, p. 543-555.
19.
Matter, M. L.,
and
G. W. Laurie.
A novel laminin E8 cell adhesion site required for lung alveolar formation in vitro.
J. Cell Biol.
124:
1083-1090,
1994
20.
Matter, M. L.,
and
G. W. Laurie.
A putative sub-10-kDa basement membrane activity required for lung alveolar formation in vitro.
Am. J. Physiol.
271 (Lung Cell. Mol. Physiol. 15):
L489-L494,
1996
21.
Mecham, R. P.
Receptors for laminin on mammalian cells.
FASEB J.
5:
2538-2546,
1991[Abstract].
22.
Miyamoto, S.,
H. Teramoto,
O. A. Coso,
J. S. Gukind,
P. D. Burbelo,
S. K. Akiyama,
and
K. M. Yamada.
Integrin function: molecular hierarchies of cytoskeletal and signaling molecules.
J. Cell Biol.
131:
791-805,
1995
23.
Odom, M.,
J. Snyder,
V. Boggaram,
and
C. Mendelson.
Glucocorticoid regulation of the major surfactant associated protein (SP-A) and its messenger ribonucleic acid and of morphological development of human fetal lung in vitro.
Endocrinology
123:
1712-1720,
1988[Abstract].
24.
Rannels, D. E.,
and
S. R. Rannels.
Influence of the extracellular matrix on type 2 cell differentiation.
Chest
96:
165-173,
1989
25.
Roskelley, C. D.,
P. Y. Desprez,
and
M. J. Bissell.
Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction.
Proc. Natl. Acad. Sci. USA
91:
12378-12382,
1994
26.
Sastry, J. K.,
and
A. F. Horwitz.
Integrin cytoplasmic domains: mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signaling.
Curr. Opin. Cell Biol.
5:
819-831,
1993[Medline].
27.
Shannon, J. M.,
P. A. Emrie,
J. H. Fisher,
Y. Kuroki,
S. D. Jennings,
and
R. J. Mason.
Effect of a reconstituted basement membrane on expression of surfactant apoproteins in cultured adult rat alveolar type II cells.
Am. J. Respir. Cell Mol. Biol.
2:
183-192,
1990.
28.
Shannon, J. M.,
S. D. Jennings,
and
L. D. Nielsen.
Modulation of alveolar type II cell differentiated function in vitro.
Am. J. Physiol.
262 (Lung Cell. Mol. Physiol. 6):
L427-L436,
1992
29.
Shannon, J. M.,
R. J. Mason,
and
S. D. Jennings.
Functional differentiation of alveolar type II epithelial cells in vitro: effects of cell shape, cell-matrix interactions, and cell-cell interactions.
Biochim. Biophys. Acta
931:
143-156,
1987[Medline].
30.
Streuli, C. H.,
N. Bailey,
and
M. J. Bissell.
Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity.
J. Cell Biol.
115:
1383-1395,
1991
31.
Streuli, C. H.,
C. Schmidhauser,
N. Bailey,
P. Yurchenco,
A. P. N. Skubitz,
C. Roskelly,
and
M. J. Bissell.
Laminin mediates tissue-specific gene expression in mammary epithelia.
J. Cell Biol.
129:
591-603,
1995
32.
Sympson, C. J.,
and
T. E. Geoghegan.
Actin gene expression in murine erythroleukemia cells treated with cytochalasin D.
Exp. Cell Res.
189:
28-32,
1990[Medline].
33.
Varedi, M.,
E. E. Tredget,
P. G. Scott,
Y. J. Shen,
and
A. Ghahary.
Alteration in cell morphology triggers transforming growth factor-beta 1, collagenase, and tissue inhibitor of metalloproteinases-I expression in normal and hypertrophic scar fibroblasts.
J. Invest. Dermatol.
104:
118-123,
1995[Medline].
34.
Venkatesh, V. C.,
D. M. Iannuzzi,
R. Ertsey,
and
P. L. Ballard.
Differential glucocorticoid regulation of the pulmonary hydrophobic surfactant proteins SP-B and SP-C.
Am. J. Respir. Cell Mol. Biol.
8:
222-228,
1993.
35.
Yamada, K. M.,
and
S. Miyamoto.
Integrin transmembrane signaling and cytoskeletal control.
Curr. Opin. Cell Biol.
7:
681-698,
1995[Medline].
This article has been cited by other articles:
![]() |
W. R. Rice, J. J. Conkright, C.-L. Na, M. Ikegami, J. M. Shannon, and T. E. Weaver Maintenance of the mouse type II cell phenotype in vitro Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L256 - L264. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Shannon, T. Pan, L. D. Nielsen, K. E. Edeen, and R. J. Mason Lung Fibroblasts Improve Differentiation of Rat Type II Cells in Primary Culture Am. J. Respir. Cell Mol. Biol., March 1, 2001; 24(3): 235 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Relan, Y. Yang, S. Beqaj, J. H. Miner, and L. Schuger Cell Elongation Induces Laminin {alpha}2 Chain Expression in Mouse Embryonic Mesenchymal Cells: Role in Visceral Myogenesis J. Cell Biol., December 13, 1999; 147(6): 1341 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zuk, J. P. Belk, and A. Jacobson Temperature-Sensitive Mutations in the Saccharomyces cerevisiae MRT4, GRC5, SLA2 and THS1 Genes Result in Defects in mRNA Turnover Genetics, September 1, 1999; 153(1): 35 - 47. [Abstract] [Full Text] |
||||
![]() |
R. J. Mason, M. C. Lewis, K. E. Edeen, K. McCormick-Shannon, L. D. Nielsen, and J. M. Shannon Maintenance of surfactant protein A and D secretion by rat alveolar type II cells in vitro Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L249 - L258. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |